American Journal of Veterinary Research · 1992 · 15 citations · 23 references
Veterinary MedicinePharmacotherapyVeterinary PharmacologyProduction Animal MedicineRuminant MedicineRuminant NutritionCalf HealthEndotoxin ControlNeonatal MedicineEndotoxin ToxicityEscherichia ColiLactate AcidosisLactic AcidosisNeonatal Calf HealthNeonatal Septicemia
The clinical efficacy of the lazaroid, tirilazad mesylate, a new therapeutic agent for prophylaxis and treatment of endotoxemia, was evaluated in 24 neonatal Holstein calves. Endotoxemia was induced by IV infusion of commercial Escherichia coli lipopolysaccharide (3.25 micrograms/kg of body weight) over 3 hours. Group-1 calves were given endotoxin alone; group-2 calves were given an infusion of 0.9% sterile saline solution, then were treated with tirilazad mesylate (1.5 mg/kg) 1 hour after the infusion was started. Group-3 calves were treated with tirilazad mesylate 1 hour after the start of the endotoxin infusion, and group-4 calves were given tirilazad mesylate 1 hour before the start of the endotoxin infusion. Clinical signs of endotoxemia were mitigated by tirilazad mesylate. In addition, tirilazad mesylate protected calves from endotoxin-induced hyperglycemia; treatment after endotoxin infusion decreased the severity of hypoglycemia and prevented lactic acidosis. Treatment with tirilazad mesylate after initiation of endotoxin infusion was as protective as was pretreatment.
23
Effects of the 21-aminosteroid U74006F on experimental head injury in mice
Edward D. Hall, Patricia A. Yonkers, John M. McCall et al. · Journal of neurosurgery · 1988 · 296 citations
Medicine, Neuroscience, Pharmacology +17
J. Mark Braughler, R L Chase, G L Neff et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 141 citations